Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 27745 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.111beta-hydroxysteroid dehydrogenase deficiency 15718388 Interactions between 11beta-hydroxysteroid dehydrogenase and COX-2 in kidney. causal interaction
ongoing research
unassigned
4
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 8601574 Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. causal interaction
therapeutic application
unassigned
3
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 8840961 Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. causal interaction
ongoing research
therapeutic application
unassigned
4
1
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 9149043 Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats. ongoing research
therapeutic application
unassigned
3
1
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 9439679 Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats. causal interaction
ongoing research
therapeutic application
unassigned
4
4
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 9458081 Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. causal interaction
therapeutic application
unassigned
4
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 10893436 Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats. ongoing research
unassigned
2
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 11197048 Non-steroidal anti-inflammatory drugs with different cyclooxygenase inhibitory profiles that prevent aberrant crypt foci formation but vary in acute gastrotoxicity in a rat model. ongoing research
therapeutic application
unassigned
1
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 11216473 COX-2 and iNOS, good targets for chemoprevention of colon cancer. causal interaction
ongoing research
therapeutic application
unassigned
4
3
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 11280748 Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. causal interaction
diagnostic usage
ongoing research
therapeutic application
4
3
3
1
Results 1 - 10 of 27745 > >>